TP53 and neoplasm: Expectedly, patients with TP53-mutated tumors (all tumor types combined) who were treated with carboplatin, paclitaxel, or fluorouracil chemotherapy experienced slightly longer OS than patients with TP53-wt tumors (Supplementary Fig. S8).